Literature DB >> 35695922

Prevalence of coronary calcification on preoperative computed tomography and its management in thoracic surgery.

Ryusuke Machino1, Koichiro Shimoyama2, Koji Oku3, Kazumi Yamasaki4, Tsutomu Tagawa2.   

Abstract

PURPOSE: We investigated the preoperative assessment of coronary artery calcification using computed tomography for appropriate intraoperative management to reduce the risk of perioperative cardiac complications during pulmonary resection.
METHODS: Patients (n = 665) who underwent anatomical lung resection were examined. The extent of preoperative asymptomatic coronary artery stenosis or cardiac complications in patients with coronary artery calcification was assessed. In addition, the risk factors for perioperative cardiac complications were determined.
RESULTS: Coronary artery calcification was detected in 233 (35.0%) asymptomatic patients. Nineteen (8.2%) patients with coronary artery calcification had coronary artery stenosis ≥ 75%. Percutaneous coronary intervention was performed preoperatively (n = 3) and postoperatively (n = 10), and preoperative drug intervention was performed in 10 cases. One case of severe postoperative cardiac complications and 20 cases of mild postoperative cardiac complications, including those without coronary artery calcification, occurred. Patients with calcified coronary arteries were at risk of cardiovascular complications in the perioperative period. However, patients with coronary artery calcification who underwent preoperative cardiology intervention had no significant perioperative cardiovascular complications.
CONCLUSIONS: Coronary artery calcification detected on preoperative computed tomography is a risk factor for perioperative cardiovascular complications. Early intervention may reduce the risk of such complications.
© 2022. The Author(s).

Entities:  

Keywords:  Coronary artery calcification; Plain CT; Pulmonary resection

Year:  2022        PMID: 35695922     DOI: 10.1007/s00595-022-02532-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  21 in total

1.  Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial.

Authors:  Vera Bittner; Marnie Bertolet; Rafael Barraza Felix; Michael E Farkouh; Suzanne Goldberg; Kodangudi B Ramanathan; J Bruce Redmon; Laurence Sperling; Martin K Rutter
Journal:  J Am Coll Cardiol       Date:  2015-08-18       Impact factor: 24.094

Review 2.  ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing).

Authors:  R J Gibbons; G J Balady; J W Beasley; J T Bricker; W F Duvernoy; V F Froelicher; D B Mark; T H Marwick; B D McCallister; P D Thompson; W L Winters; F G Yanowitz; J L Ritchie; R J Gibbons; M D Cheitlin; K A Eagle; T J Gardner; A Garson; R P Lewis; R A O'Rourke; T J Ryan
Journal:  J Am Coll Cardiol       Date:  1997-07       Impact factor: 24.094

3.  Computed tomographic coronary angiography in risk stratification prior to non-cardiac surgery: a systematic review and meta-analysis.

Authors:  Anoop N Koshy; Francis Jonathan Ha; Paul J Gow; Hui-Chen Han; F M Amirul-Islam; Han S Lim; Andrew W Teh; Omar Farouque
Journal:  Heart       Date:  2019-04-24       Impact factor: 5.994

4.  Incidental Coronary Artery Calcification and Stroke Risk in Patients With Atrial Fibrillation.

Authors:  Dustin Hillerson; Thomas Wool; Gbolahan O Ogunbayo; Vincent L Sorrell; Steve W Leung
Journal:  AJR Am J Roentgenol       Date:  2020-04-29       Impact factor: 3.959

Review 5.  Coronary Calcium Score and Cardiovascular Risk.

Authors:  Philip Greenland; Michael J Blaha; Matthew J Budoff; Raimund Erbel; Karol E Watson
Journal:  J Am Coll Cardiol       Date:  2018-07-24       Impact factor: 24.094

Review 6.  New tools for coronary risk assessment: what are their advantages and limitations?

Authors:  Thomas A Pearson
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

Review 7.  Extracoronary Thoracic and Coronary Artery Calcifications on Chest CT for Lung Cancer Screening: Association with Established Cardiovascular Risk Factors - The "CT-Risk" Trial.

Authors:  Timm Dirrichs; Tobias Penzkofer; Sebastian D Reinartz; Thomas Kraus; Andreas H Mahnken; Christiane K Kuhl
Journal:  Acad Radiol       Date:  2015-05-07       Impact factor: 3.173

Review 8.  Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis.

Authors:  R Gianrossi; R Detrano; D Mulvihill; K Lehmann; P Dubach; A Colombo; D McArthur; V Froelicher
Journal:  Circulation       Date:  1989-07       Impact factor: 29.690

9.  Initial Invasive or Conservative Strategy for Stable Coronary Disease.

Authors:  David J Maron; Judith S Hochman; Harmony R Reynolds; Sripal Bangalore; Sean M O'Brien; William E Boden; Bernard R Chaitman; Roxy Senior; Jose López-Sendón; Karen P Alexander; Renato D Lopes; Leslee J Shaw; Jeffrey S Berger; Jonathan D Newman; Mandeep S Sidhu; Shaun G Goodman; Witold Ruzyllo; Gilbert Gosselin; Aldo P Maggioni; Harvey D White; Balram Bhargava; James K Min; G B John Mancini; Daniel S Berman; Michael H Picard; Raymond Y Kwong; Ziad A Ali; Daniel B Mark; John A Spertus; Mangalath N Krishnan; Ahmed Elghamaz; Nagaraja Moorthy; Whady A Hueb; Marcin Demkow; Kreton Mavromatis; Olga Bockeria; Jesus Peteiro; Todd D Miller; Hanna Szwed; Rolf Doerr; Matyas Keltai; Joseph B Selvanayagam; P Gabriel Steg; Claes Held; Shun Kohsaka; Stavroula Mavromichalis; Ruth Kirby; Neal O Jeffries; Frank E Harrell; Frank W Rockhold; Samuel Broderick; T Bruce Ferguson; David O Williams; Robert A Harrington; Gregg W Stone; Yves Rosenberg
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245

Review 10.  Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force.

Authors:  Mark Helfand; David I Buckley; Michele Freeman; Rongwei Fu; Kevin Rogers; Craig Fleming; Linda L Humphrey
Journal:  Ann Intern Med       Date:  2009-10-06       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.